(+)-Menthol

(+)-Menthol

SCHEMBL1709231

CC(C)C1CC[C@@H](C)C[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of (+)-Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 5/20 1.00
TRPA1 known ✓ O75762 2/20 1.00
EPHX1 P07099 3/20 0.52
ALDH1A1 P00352 1/20 0.41
KCNA5 P22460 1/20 0.39
TRPV1 Q8NER1 3/20 0.38
LMNA P02545 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Menthol SCHEMBL10072505 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL15449169 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Isomenthol SCHEMBL677675 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Racementhol SCHEMBL521946 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL9968934 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+) Neomenthol SCHEMBL260049 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL12646785 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL13059620 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL20771511 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL2454317 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240225915-A1 COMPOSITIONS FOR FIGHTING MALODORS SYMRISE AG (DE) 2024-07-11 US disclosed
WO-2023241952-A1 SHELL-AND-TUBE HEAT EXCHANGE REACTOR FOR CARRYING OUT A CATALYTIC GAS-PHASE PARTIAL OXIDATION REACTION AND PROCESS FOR CARRYING OUT A CATALYTIC GAS-PHASE PARTIAL OXIDATION BASF SE (DE) 2023-12-21 WO disclosed
US-11738088-B2 Boryl ethers, carbonates, and cyclic acetals as oxidatively-triggered drug delivery vehicles University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2023-08-29 US disclosed
EP-3470515-B1 METHOD FOR THE BIOCATALYTIC CYCLISATION OF TERPENES AND CYCLASE MUTANTS WHICH CAN BE USED IN SAME BASF SE (DE) 2022-07-13 EP disclosed
US-11344488-B2 Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative TAKASAGO INTERNATIONAL CORPORATION (JP) 2022-05-31 US disclosed
US-20220120734-A1 SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME MARS, INCORPORATED (US) 2022-04-21 US disclosed
US-20210363174-A1 CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH ENDOGENOUS GROUPS BRIGHAM YOUNG UNIVERSITY (US) 2021-11-25 US disclosed
WO-2021109704-A1 CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF 罗胥恩 2021-06-10 WO disclosed
EP-3489213-B1 COMPOSITION FOR USE IN A METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE CARBONYL COMPOUNDS BASF SE (DE) 2021-04-28 EP disclosed
US-20200407373-A1 BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF QPEX BIOPHARMA, INC. 2020-12-31 US disclosed
US-20080269528-A1 Method for the Production of Optically Active Carbonyl BASF AKTIENGESELLSCHAFT (DE) 2008-10-30 US disclosed
US-20080269528-A1 Method for the Production of Optically Active Carbonyl BASF AKTIENGESELLSCHAFT (DE) 2008-10-30 US disclosed
US-20080146672-A1 Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue DENTON MARCIA MARYE 2008-06-19 US disclosed
US-20080139852-A1 Method For The Production Of Menthol BASF AKTIENGESELLSCHAFT (DE) 2008-06-12 US disclosed
US-20080139852-A1 Method For The Production Of Menthol BASF AKTIENGESELLSCHAFT (DE) 2008-06-12 US disclosed
US-7247743-B1 Process for making monomenthyl esters MILLENNIUM SPECIALTY CHEMICALS, INC. (US) 2007-07-24 US disclosed
US-7189760-B2 Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine MILLENNIUM SPECIALTY CHEMICALS (US) 2007-03-13 US disclosed
US-7189760-B2 Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine MILLENNIUM SPECIALTY CHEMICALS (US) 2007-03-13 US disclosed
US-7169774-B2 Cephalotaxane derivatives and their processes of preparation and purification STRAGEN PHARMA S.A. (CH) 2007-01-30 US disclosed
US-7169774-B2 Cephalotaxane derivatives and their processes of preparation and purification STRAGEN PHARMA S.A. (CH) 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210363174-A1 CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH ENDOGENOUS GROUPS FPR3, NR3C2, HSD17B7 TRPM8 727/4885TRPA1 1919/4885EPHX1 3827/4885
US-11344488-B2 Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative CNR2, ADRB2, TRPA1 TRPM8 50/4885TRPA1 3/4885EPHX1 2858/4885
US-11738088-B2 Boryl ethers, carbonates, and cyclic acetals as oxidatively-triggered drug delivery vehicles BRD8, CA4, LDHA TRPM8 2725/4885TRPA1 4410/4885EPHX1 1469/4885
US-20200407373-A1 BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF BTD, BLVRB, BLK TRPM8 4760/4885TRPA1 4704/4885EPHX1 2571/4885
US-20080269528-A1 Method for the Production of Optically Active Carbonyl CBR1, CBR3, HMOX1 TRPM8 2762/4885TRPA1 1175/4885EPHX1 504/4885
US-20220120734-A1 SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME TAS2R1, TAS2R50, TAS2R3 TRPM8 167/4885TRPA1 86/4885EPHX1 3328/4885
US-20080139852-A1 Method For The Production Of Menthol NISCH, CYP8B1, MSMO1 TRPM8 300/4885TRPA1 419/4885EPHX1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.